118 related articles for article (PubMed ID: 37698493)
1. Racial differences in serum chemokines in prostate cancer patients.
Karan D; Wick J; Dubey S; Kumar-Sinha C; Siddiqui J; Kunju LP; Iczkowski KA; Chinnaiyan AM
Cancer; 2023 Dec; 129(23):3783-3789. PubMed ID: 37698493
[TBL] [Abstract][Full Text] [Related]
2. Pilot and feasibility study of serum chemokines as markers to distinguish prostatic disease in men with low total serum PSA.
Macoska JA; Begley LA; Dunn RL; Siddiqui J; Wei JT; Sarma AV
Prostate; 2008 Mar; 68(4):442-52. PubMed ID: 18196514
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the perioperative changes of exosomal immune-related cytokines induced by prostatectomy in early-stage prostate cancer patients.
Macías M; García-Cortés Á; Torres M; Ancizu-Marckert J; Ignacio Pascual J; Díez-Caballero F; Enrique Robles J; Rosell D; Miñana B; Mateos B; Ajona D; Sánchez-Bayona R; Bedialauneta O; Chocarro S; Navarro A; Andueza MP; Gúrpide A; Luis Perez-Gracia J; Alegre E; González Á
Cytokine; 2021 May; 141():155471. PubMed ID: 33607398
[TBL] [Abstract][Full Text] [Related]
4. Racial differences in serum prostate-specific antigen (PSA) doubling time, histopathological variables and long-term PSA recurrence between African-American and white American men undergoing radical prostatectomy for clinically localized prostate cancer.
Tewari A; Horninger W; Badani KK; Hasan M; Coon S; Crawford ED; Gamito EJ; Wei J; Taub D; Montie J; Porter C; Divine GW; Bartsch G; Menon M
BJU Int; 2005 Jul; 96(1):29-33. PubMed ID: 15963115
[TBL] [Abstract][Full Text] [Related]
5. Does Any Racial Disparity Exist in Oncologic Outcomes After Primary Cryotherapy for Prostate Cancer? A Matched-pair Comparative Analysis of the Cryo On-Line Data Registry.
Aminsharifi A; Polascik TJ; Tsivian M; Schulman A; Tsivian E; Tay KJ; Elshafei A; Jones JS
Clin Genitourin Cancer; 2018 Oct; 16(5):e1073-e1076. PubMed ID: 30054221
[TBL] [Abstract][Full Text] [Related]
6. African-American men with prostate cancer have larger tumor volume than Caucasian men despite no difference in serum prostate specific antigen.
Fuletra JG; Kamenko A; Ramsey F; Eun DD; Reese AC
Can J Urol; 2018 Feb; 25(1):9193-9198. PubMed ID: 29524974
[TBL] [Abstract][Full Text] [Related]
7. African-American men with nonpalpable prostate cancer exhibit greater tumor volume than matched white men.
Sanchez-Ortiz RF; Troncoso P; Babaian RJ; Lloreta J; Johnston DA; Pettaway CA
Cancer; 2006 Jul; 107(1):75-82. PubMed ID: 16736511
[TBL] [Abstract][Full Text] [Related]
8. Obese African-Americans with prostate cancer (T1c and a prostate-specific antigen, PSA, level of <10 ng/mL) have higher-risk pathological features and a greater risk of PSA recurrence than non-African-Americans.
Caire AA; Sun L; Polascik TJ; Albala DM; Moul JW
BJU Int; 2010 Oct; 106(8):1157-60. PubMed ID: 20367635
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic analysis identifies factors driving racial disparity in prostate cancer.
Rai R; Yadav SS; Pan H; Khan I; O'Connor J; Alshalalfa M; Davicioni E; Taioli E; Elemento O; Tewari AK; Yadav KK
Cancer Rep (Hoboken); 2019 Apr; 2(2):e1153. PubMed ID: 32721098
[TBL] [Abstract][Full Text] [Related]
10. Reduced mitochondrial DNA content associates with poor prognosis of prostate cancer in African American men.
Koochekpour S; Marlowe T; Singh KK; Attwood K; Chandra D
PLoS One; 2013; 8(9):e74688. PubMed ID: 24086362
[TBL] [Abstract][Full Text] [Related]
11. Elevated Serum Levels of CCL23 Are Associated with Poor Outcome after Resection of Biliary Tract Cancer.
Roderburg C; Labuhn S; Bednarsch J; Lang SA; Schneider AT; Hammerich L; Vucur M; Ulmer TF; Neumann UP; Luedde T; Loosen SH
Mediators Inflamm; 2022; 2022():6195004. PubMed ID: 36505756
[TBL] [Abstract][Full Text] [Related]
12. The impact of African American race on prostate cancer detection on repeat prostate biopsy in a veteran population.
Sterling WA; Weiner J; Schreiber D; Mehta K; Weiss JP
Int Urol Nephrol; 2016 Dec; 48(12):2015-2021. PubMed ID: 27580731
[TBL] [Abstract][Full Text] [Related]
13. CXCL5 promotes prostate cancer progression.
Begley LA; Kasina S; Mehra R; Adsule S; Admon AJ; Lonigro RJ; Chinnaiyan AM; Macoska JA
Neoplasia; 2008 Mar; 10(3):244-54. PubMed ID: 18320069
[TBL] [Abstract][Full Text] [Related]
14. High circulating estrogens and selective expression of ERβ in prostate tumors of Americans: implications for racial disparity of prostate cancer.
Abd Elmageed ZY; Moroz K; Srivastav SK; Fang Z; Crawford BE; Moparty K; Thomas R; Abdel-Mageed AB
Carcinogenesis; 2013 Sep; 34(9):2017-23. PubMed ID: 23658372
[TBL] [Abstract][Full Text] [Related]
15. SPINK1 expression is enriched in African American prostate cancer but is not associated with altered immune infiltration or oncologic outcomes post-prostatectomy.
Faisal FA; Kaur HB; Tosoian JJ; Tomlins SA; Schaeffer EM; Lotan TL
Prostate Cancer Prostatic Dis; 2019 Dec; 22(4):552-559. PubMed ID: 30850708
[TBL] [Abstract][Full Text] [Related]
16. Racial variation in prostate needle biopsy templates directed anterior to the peripheral zone.
Feibus AH; Levy J; McCaslin IR; Doucet ME; Sholl AB; Moparty K; Thomas R; Sartor O; Silberstein JL
Urol Oncol; 2016 Aug; 34(8):336.e1-6. PubMed ID: 27155916
[TBL] [Abstract][Full Text] [Related]
17. Survival of African American and non-Hispanic white men with prostate cancer in an equal-access health care system.
Riviere P; Luterstein E; Kumar A; Vitzthum LK; Deka R; Sarkar RR; Bryant AK; Bruggeman A; Einck JP; Murphy JD; Martínez ME; Rose BS
Cancer; 2020 Apr; 126(8):1683-1690. PubMed ID: 31984482
[TBL] [Abstract][Full Text] [Related]
18. Associations of four circulating chemokines with multiple atherosclerosis phenotypes in a large population-based sample: results from the dallas heart study.
Castillo L; Rohatgi A; Ayers CR; Owens AW; Das SR; Khera A; McGuire DK; de Lemos JA
J Interferon Cytokine Res; 2010 May; 30(5):339-47. PubMed ID: 20187767
[TBL] [Abstract][Full Text] [Related]
19. African-American men with low-grade prostate cancer have higher tumor burdens: results from the Duke Prostate Center.
Tsivian M; Bañez LL; Keto CJ; Abern MR; Qi P; Gerber L; Moul JW; Polascik TJ
Prostate Cancer Prostatic Dis; 2013 Mar; 16(1):91-4. PubMed ID: 23032361
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of miR-130b Contributes to Risk of Poor Prognosis and Racial Disparity in African-American Prostate Cancer.
Hashimoto Y; Shiina M; Dasgupta P; Kulkarni P; Kato T; Wong RK; Tanaka Y; Shahryari V; Maekawa S; Yamamura S; Saini S; Deng G; Tabatabai ZL; Majid S; Dahiya R
Cancer Prev Res (Phila); 2019 Sep; 12(9):585-598. PubMed ID: 31266828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
